Kazumasa Muratsu

Title: Kazumasa Muratsu: Innovator in Coenzyme Formulations

Introduction

Kazumasa Muratsu is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of pharmaceutical formulations, particularly in the area of coenzyme Q.sub.10. His work focuses on creating stable and effective formulations for intravenous use.

Latest Patents

Kazumasa Muratsu holds a patent for "Formulations of coenzyme Q.sub.10 for intravenous use." This invention comprises a stable and non-toxic coenzyme Q.sub.10 formulation suitable for intravenous administration to an animal. The formulation aims to produce clinically effective blood levels of coenzyme Q.sub.10, which are generally agreed to be between about 2 µg/ml and about 4 µg/ml. The formulation consists essentially of a clinically accepted fatty emulsion that includes an oil phase with coenzyme Q.sub.10 dissolved in it. The preferred concentration of coenzyme Q.sub.10 in the formulation is between about 7.5 µg/ml and about 30 µg/ml. The clinically accepted fatty emulsion comprises at least one vegetable oil, such as corn oil, peanut oil, safflower oil, olive oil, or soybean oil.

Career Highlights

Kazumasa Muratsu is affiliated with the University of Texas System, where he continues to contribute to research and innovation in his field. His work has implications for improving the delivery and efficacy of coenzyme Q.sub.10 in clinical settings.

Collaborations

Kazumasa Muratsu has collaborated with Karl A. Folkers, a prominent figure in the field of biochemistry. Their partnership has likely enhanced the research and development of coenzyme formulations.

Conclusion

Kazumasa Muratsu's innovative work in coenzyme Q.sub.10 formulations represents a significant advancement in pharmaceutical science. His contributions are poised to impact clinical practices positively.